Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study

Blood. 2015 Sep 10;126(11):1392-4. doi: 10.1182/blood-2015-05-647420.

¹ Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
² First Department of of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
³ Theageneion Cancer Center, Thessaloniki, Greece.
⁴ Department of Hematology, University of Patras School of Medicine, Patras, Greece.
⁵ Metaxa Cancer Center, Piraeus, Greece.
⁶ Department of Hematology, G. Genimatas Hospital, Athens, Greece.
⁷ Department of Hematology and Bone Marrow Transplant, Evangelismos Hospital, Athens, Greece.
⁸ School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
⁹ Second Department of Internal Medicine, National and Kapodistrian University of Athens, Haidari, Greece.
¹⁰ Department of Hematology, University of Ioannina School of Medicine, Ioannina, Greece.
¹¹ Henry Dunant Hospital, Athens, Greece.

No abstract available

Publication types